Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Asthma 2Smoking 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Lymphoma, Follicular 1Leukemia 1Hematologic Neoplasms 1Graft vs Host Disease 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

Tacrolimus 37Methotrexate 27Cyclophosphamide 27Mycophenolic Acid 21fludarabine phosphate 19Busulfan 19Antilymphocyte Serum 19Cyclosporine 18Sirolimus 16Methylprednisolone 16fludarabine 15Peripheral Blood Stem Cell Transplantation 15Melphalan 14Filgrastim 13Radiotherapy 12Whole-Body Irradiation 8Granulocyte Colony-Stimulating Factor 8thymoglobulin 6Stem Cell Transplantation 6Rituximab 6Prednisone 6Pentostatin 6Hematopoietic Stem Cell Transplantation 5Etoposide 5ruxolitinib 4Thiotepa 4Flow Cytometry 4Cytarabine 4Cyclosporins 4Cord Blood Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Graft vs Host Disease × Budesonide × Clear all
NCT00180089 2010-03-30

Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation

Technische Universität Dresden

Phase 3 Completed
242 enrolled
Other hematologic neoplasm

Graft vs Host Disease, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡